search URL:,https://patents.google.com/?assignee=INTERCEPT+PHARMACEUTICALS+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
US-10155787-B2,Preparation and uses of obeticholic acid ,"Intercept Pharmaceuticals, Inc.","André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross, Emma Sharp, Fiona Dubas-Fisher, Alex Eberlin",2012-06-19,2015-11-20,2018-12-18,2018-12-18,https://patents.google.com/patent/US10155787B2/en,https://patentimages.storage.googleapis.com/23/ed/67/c105eb09bcc3c7/US10155787-20181218-D00001.png
US-9732117-B2,Steroids as agonists for FXR ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2001-03-12,2016-02-05,2017-08-15,2017-08-15,https://patents.google.com/patent/US9732117B2/en,
CA-2608539-C,Process for preparing 3.alpha.(.beta.)-7.alpha.(.beta.)-dihydroxy-6.alpha.(.beta.)-alkyl-5.beta.-cholanic acid ,"Erregierre S.P.A., Massimo Ferrari, Roberto Pellicciari, Intercept Pharmaceuticals, Inc.","Massimo Ferrari, Roberto Pellicciari",2005-05-19,2006-05-19,2013-02-26,2013-02-26,https://patents.google.com/patent/CA2608539C/en,
EP-2040713-B1,Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions ,Intercept Pharmaceuticals Inc.,"Roberto Pellicciari, Stefano Fiorucci, Mark Pruzanski",2006-06-27,2007-06-27,2014-06-18,2014-06-18,https://patents.google.com/patent/EP2040713B1/en,https://patentimages.storage.googleapis.com/98/7a/71/ca325a4bae8b20/imgf0001.png
AU-2008209566-B2,23-substituted bile acids as TGR5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2007-01-19,2008-01-18,2012-09-20,2012-09-20,https://patents.google.com/patent/AU2008209566B2/en,
US-7812011-B2,Steroid agonist for FXR ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2004-02-26,2005-02-28,2010-10-12,2010-10-12,https://patents.google.com/patent/US7812011B2/en,
US-7858608-B2,Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Stefano Fiorucci, Mark Pruzanski",2006-02-14,2009-05-04,2010-12-28,2010-12-28,https://patents.google.com/patent/US7858608B2/en,https://patentimages.storage.googleapis.com/f6/86/e1/29eda32d1a1e02/US07858608-20101228-D00001.png
US-9498484-B2,Treatment of fibrosis using FXR ligands ,"Intercept Pharmaceuticals, Inc.","Stefano Fiorucci, Roberto Pellicciari, Mark Pruzanski",2004-03-12,2005-03-14,2016-11-22,2016-11-22,https://patents.google.com/patent/US9498484B2/en,https://patentimages.storage.googleapis.com/10/b4/c7/5532467b86b30f/US09498484-20161122-D00001.png
DK-2997035-T3,11-hydroxy-6-substituted derivatives of bile acids and amino acid conjugates thereof as Farnesoid X-receptor modulators ,Intercept Pharmaceuticals Inc,Roberto Pellicciari,2013-05-14,2014-05-14,2018-07-02,2018-07-02,https://patents.google.com/patent/DK2997035T3/en,
AU-2002308295-A1,Steroids as agonists for FXR ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2001-03-12,2002-02-21,2003-03-20,,https://patents.google.com/patent/AU2002308295A1/en,
US-9650409-B2,TGR5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2008-11-19,2013-04-26,2017-05-16,2017-05-16,https://patents.google.com/patent/US9650409B2/en,https://patentimages.storage.googleapis.com/bb/a5/1f/c587fcfd8b2d2d/US09650409-20170516-D00001.png
CA-2732323-C,Tgr5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc., Roberto Pellicciari",Roberto Pellicciari,2008-07-30,2009-07-30,2017-06-27,2017-06-27,https://patents.google.com/patent/CA2732323C/en,
US-2006252670-A1,Method of reducing drug-induced adverse side effects in a patient ,Intercept Pharmaceuticals Inc.,"Stefano Fiorucci, Roberto Pellicciari, Mark Pruzanski",2004-10-14,2005-10-13,2006-11-09,,https://patents.google.com/patent/US20060252670A1/en,
US-2016213689-A1,Treatment of Pulmonary Disease ,"Intercept Pharmaceuticals, Inc.","Mark Pruzanski, Luciano Adorini",2012-11-28,2016-01-28,2016-07-28,,https://patents.google.com/patent/US20160213689A1/en,https://patentimages.storage.googleapis.com/8f/96/36/285eb7ab997ea6/US20160213689A1-20160728-D00001.png
AU-2009316484-B2,TGR5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2008-11-19,2009-11-19,2015-04-16,2015-04-16,https://patents.google.com/patent/AU2009316484B2/en,
ES-2655034-T3,Process for preparing bile acid derivatives ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Antimo GIOIELLO",2012-10-26,2013-10-25,2018-02-16,2018-02-16,https://patents.google.com/patent/ES2655034T3/en,
EP-1947108-A1,TGR5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc.",Roberto Prof. Pellicciari,2007-01-19,2007-01-19,2008-07-23,,https://patents.google.com/patent/EP1947108A1/en,
WO-2016205475-A2,Tgr5 modulators and methods of use thereof ,"Intercept Pharmaceuticals, Inc., Les Laboratoires Servier","Roberto Pellicciari, Antimo GIOIELLO, Antonio Macchiarulo, Francoise Perron-Sierra, Klaus Seedorf",2015-06-19,2016-06-16,2016-12-22,,https://patents.google.com/patent/WO2016205475A2/en,
WO-2017027396-A1,Methods for preparation of bile acids and derivatives thereof ,"Intercept Pharmaceuticals, Inc.",Gabriel M. GALVIN,2015-08-07,2016-08-05,2017-02-16,,https://patents.google.com/patent/WO2017027396A1/en,
US-10052337-B2,Compositions of obeticholic acid and methods of use ,"Intercept Pharmaceuticals, Inc.","Richard Gail Lancaster, Kay K. Olmstead, Masashi Kagihiro, Mitsuhiro Matono, Ikuko Taoka, Mark Pruzanski, David Shapiro, Roya Hooshmand-Rad, Richard Pencek, Cathi Sciacca, Lise Eliot, Jeffrey Edwards, Leigh A. MacConell, Tonya K. Marmon",2015-04-27,2016-04-26,2018-08-21,2018-08-21,https://patents.google.com/patent/US10052337B2/en,https://patentimages.storage.googleapis.com/e5/8f/b0/92e17db04db569/US10052337-20180821-D00000.png
US-2018008616-A1,Pharmaceutical compositions for combination therapy ,"Intercept Pharmaceuticals, Inc.","Mark Pruzanski, Luciano Adorini",2015-02-06,2016-02-05,2018-01-11,,https://patents.google.com/patent/US20180008616A1/en,https://patentimages.storage.googleapis.com/ab/ae/f7/4bf131e4741ed0/US20180008616A1-20180111-D00001.png
US-2019002493-A1,3-desoxy derivative and pharmaceutical compositions thereof ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Antimo Gioiello",2016-03-11,2018-09-06,2019-01-03,,https://patents.google.com/patent/US20190002493A1/en,https://patentimages.storage.googleapis.com/ff/e8/99/294765bcf33a4c/US20190002493A1-20190103-D00001.png
US-9982008-B2,Preparation and uses of obeticholic acid ,"Intercept Pharmaceuticals, Inc.","André Steiner, Heidi Waenerlund Poulsen, Emilie Jolibois, Melissa Rewolinski, Ralf Gross, Emma Sharp, Fiona Dubas-Fisher, Alex Eberlin",2012-06-19,2015-12-22,2018-05-29,2018-05-29,https://patents.google.com/patent/US9982008B2/en,https://patentimages.storage.googleapis.com/ee/8c/c9/045c93b036c366/US09982008-20180529-D00001.png
US-2018117065-A1,Pharmaceutical compositions for combination therapy ,"Intercept Pharmaceuticals, Inc.","Mark Pruzanski, Luciano Adorini",2015-04-07,2016-04-06,2018-05-03,,https://patents.google.com/patent/US20180117065A1/en,https://patentimages.storage.googleapis.com/9e/88/9b/742aba3ab9b1a9/US20180117065A1-20180503-D00001.png
KR-20180095070-A,Polymorphic crystalline forms of obetic acid ,"인터셉트 파마슈티컬즈, 인크.","안드레 슈타이너, 하이디 웨넬룬드 포울센, 에밀리 졸리부아, 멜리사 레볼린스키, 랄프 그로스, 엠마 샤프, 피오나 두바스-피셔, 알렉스 에벌린",2015-12-22,2016-01-08,2018-08-24,,https://patents.google.com/patent/KR20180095070A/en,https://patentimages.storage.googleapis.com/bf/a7/6a/6880f7a2409e0e/pct00057.png
CA-2999302-A1,Methods and intermediates for the preparation bile acid derivatives ,"Intercept Pharmaceuticals, Inc., Kevin SCHAAB, Paul E. Whitley, Flavio CHAVEZ, Kayla R. Iorga","Kevin SCHAAB, Paul E. Whitley, Flavio CHAVEZ, Kayla R. Iorga",2015-09-24,2016-09-23,2017-03-30,,https://patents.google.com/patent/CA2999302A1/en,
EP-3359160-A1,Farnesoid x receptor modulators ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Antimo GIOIELLO",2015-10-07,2016-10-07,2018-08-15,,https://patents.google.com/patent/EP3359160A1/en,
EP-3328817-A1,Methods for preparation of bile acids and derivatives thereof ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Antimo GIOIELLO",2015-07-30,2016-07-22,2018-06-06,,https://patents.google.com/patent/EP3328817A1/en,
AU-2014204505-B2,TGR5 Modulators and Method of Use Thereof ,"Intercept Pharmaceuticals, Inc.",Roberto Pellicciari,2008-11-19,2014-07-18,2015-11-05,2015-11-05,https://patents.google.com/patent/AU2014204505B2/en,
US-2017296556-A1,Methods of treating cancer ,"Intercept Pharmaceuticals, Inc.","Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren",2016-04-13,2017-04-11,2017-10-19,,https://patents.google.com/patent/US20170296556A1/en,https://patentimages.storage.googleapis.com/79/88/00/69b9df9e99e42f/US20170296556A1-20171019-D00001.png
EP-3437659-A1,Medicine obtained by combining fxr agonist and arb ,"Intercept Pharmaceuticals, Inc.","Tadashi NAMISAKI, Hitoshi YOSHIJI",2016-03-28,2017-03-27,2019-02-06,,https://patents.google.com/patent/EP3437659A1/en,https://patentimages.storage.googleapis.com/b4/72/e5/83aa8d3ef17fc7/imgf0001.png
US-2018042943-A1,Methods for modulating bone density ,"Intercept Pharmaceuticals, Inc.","David Shapiro, Luciano Adorini",2015-03-09,2016-03-08,2018-02-15,,https://patents.google.com/patent/US20180042943A1/en,https://patentimages.storage.googleapis.com/c3/6a/3b/e4caad5ee1a594/US20180042943A1-20180215-D00001.png
KR-20180125574-A,Oral preparation with excellent elution property ,"인터셉트 파마슈티컬즈, 인크.","미츠히로 마토노, 데츠야 하야마",2016-03-31,2017-03-30,2018-11-23,,https://patents.google.com/patent/KR20180125574A/en,https://patentimages.storage.googleapis.com/7c/d6/01/e0f0e983fbe503/pct00030.png
US-2018256600-A1,Methods of treating cancer ,"Intercept Pharmaceuticals, Inc.","Antonio Moschetta, Jesus Maria Banales Asurmedi, Luis Bujanda Fernández de Pierola, María Jesús Perugorria Montiel, Oihane Erice Azparren",2017-03-07,2017-09-21,2018-09-13,,https://patents.google.com/patent/US20180256600A1/en,https://patentimages.storage.googleapis.com/07/4f/8d/4a75d9debe4c14/US20180256600A1-20180913-D00001.png
US-2018256602-A1,Methods of promoting hepatic regeneration ,"Intercept Pharmaceuticals, Inc.","Peter Leonardus Maria Jansen, Stephanus Willibrordus Maria Olde Damink, Franciscus Gerardus Schaap, Isabelle Anne Leclercq",2015-09-21,2016-09-21,2018-09-13,,https://patents.google.com/patent/US20180256602A1/en,https://patentimages.storage.googleapis.com/d3/3e/e7/feea58fad4716d/US20180256602A1-20180913-D00000.png
AU-2017254480-A1,Methods for the preparation of obeticholic acid and derivatives thereof ,"Intercept Pharmaceuticals, Inc.","Chandra DE, Benjamin List, Qinggang Wang",2016-04-19,2017-04-18,2018-11-15,,https://patents.google.com/patent/AU2017254480A1/en,
WO-2018222701-A1,Treatment of renal diseases with a bile acid derivative ,"Intercept Pharmaceuticals, Inc.","Moshe Levi, Luciano Adorini",2017-05-30,2018-05-30,2018-12-06,,https://patents.google.com/patent/WO2018222701A1/en,
CA-3038534-A1,Crystalline forms of a bile acid derivative ,"Intercept Pharmaceuticals, Inc., Rachel PINEDA STRAZIK, Kevin SCHAAB, Alex Eberlin, Rosa MARIA ESPINOSA","Rachel PINEDA STRAZIK, Kevin SCHAAB, Alex Eberlin, Rosa MARIA ESPINOSA",2016-09-30,2017-09-29,2018-04-05,,https://patents.google.com/patent/CA3038534A1/en,
US-2018371009-A1,Methods and intermediates for the preparation of bile acid derivatives ,"Intercept Pharmaceuticals, Inc.","Roberto Pellicciari, Antimo Gioiello, Gabriel Galvin, Ronald D Lewis, Mathew Yanik, Myoung Goo Kim, Fred Leusink, Bartjan Koning, Thomas Hensel",2017-06-23,2018-06-22,2018-12-27,,https://patents.google.com/patent/US20180371009A1/en,
WO-2018226724-A1,Treatment and prevention of diabetic eye diseases with a bile acid derivatives ,"Intercept Pharmaceuticals, Inc.","Moshe Levi, Luciano Adorini, Maria Bartolomeo Grant",2017-06-05,2018-06-05,2018-12-13,,https://patents.google.com/patent/WO2018226724A1/en,
WO-2018156916-A2,Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof ,"Intercept Pharmaceuticals, Inc","Gary D. Wu, Hongzhe LEE, Farah Babakhani, Luciano Adorini",2017-02-23,2018-02-23,2018-08-30,,https://patents.google.com/patent/WO2018156916A2/en,
WO-2019023103-A1,Isotopically labeled bile acid derivatives ,"Intercept Pharmaceuticals, Inc.","Gabriel GAVIN, Kevin SCHAAB, Matthew Yanik",2017-07-24,2018-07-23,2019-01-31,,https://patents.google.com/patent/WO2019023103A1/en,
WO-2018165269-A2,Crystalline forms of obeticholic acid ,"Intercept Pharmaceuticals, Inc","Gabriel M Galvin, Melissa REWOLINSKI",2017-03-08,2018-03-07,2018-09-13,,https://patents.google.com/patent/WO2018165269A2/en,
WO-2018164715-A1,Methods of treating cancer ,"Intercept Pharmaceuticals, Inc.","Antonio MOSCHETTA, Jesús Maria Bañales ASURMEDI, Luis Bujanda Fernandez De PIEROLA, Maria Jesus Perugorria MONTIEL, Oihane Erice AZPARREN",2017-03-07,2017-09-21,2018-09-13,,https://patents.google.com/patent/WO2018164715A1/en,
